No human is the same as another. Today, we know that our individuality is more than skin deep, from the composition of the bacteria in our bodies to the type of receptors present on tumour cells. In the field of medicine, this individuality is now being better taken into account, with ...
Publication year: 2011Source: Chemometrics and Intelligent Laboratory Systems, Available online 17 September 2011Lu Xu, De-Hua Deng, Jian-Hui Jiang, Ru-Qin Yu, Xiu-Mei Wu, ...
Reuters - The European Medicines Agency said it would look into anti-obesity medicines that contain orlistat, including Roche's Xenical and GlaxoSmithKline's Alli.
Perhaps the biggest bête noire for me is the infiltration of quackademic medicine into academic medical centers; so whenever I see particularly egregious examples, it gets my fingers twitching over the keyboard, ready to lay down some not-so-Respectful Insolence.
Perhaps the biggest bête noire for me is the infiltration of quackademic medicine into academic medical centers; so whenever I see particularly egregious examples, it gets my fingers twitching over the keyboard, ready to lay down some not-so-Respectful Insolence.
Author and surgeon Atul Gawande says effective medicine requires high-quality care and solid research. But it also requires a willingness to adapt.
This chapter provides a critical evaluation of prospective and retrospective risk assessment approaches for veterinary medicines in aquatic ecosystems and provides recommendations for possible alternative approaches for hazard characterization.
European Prescribing Information Updated to Ensure Multaq Use in
Appropriate Paroxysmal and Persistent AF Patients -
Paris, France - September 22, 2011 - Sanofi (EURONEXT: SAN and
NYSE: SNY) announced today that the Committee for Medicinal
Products...
Benefit-risk balance of anti-arrhythmic medicine remains
positive in a limited population of patients with paroxysmal or
persistent atrial fibrillation
The European Medicines Agency’s Committee for Medicinal
Products for Human Use (CHMP) has...
New recommendations to ensure continued supply and
quality assurance of manufacturing processes
The European Medicines Agency’s Committee for Medicinal
Products for Human Use (CHMP) has completed an investigation into
the production processes...
